Showing items related by title, author, creator and subject.

• The Informed Consent Process and the Use of the Exception to Informed Consent in the Clinical Trial of Diaspirin Cross-Linked Hemoglobin (DCLHb) in Severe Traumatic Hemorrhagic Shock 

  Sloan, Edward P.; Koenigsberg, Max; Houghton, Jaime; Gens, David; Cipolle, Mark; Runge, Jeffrey; Mallory, Mary Nan; Rodman, George, Jr. (DCLHb [Diaspirin Cross-linked Hemoglobin] Traumatic Hemorrhagic Shock Study Group, 1999-12)
• "Two Per Cent Isn't a Lot, but When It Comes to Death It Seems Quite a Lot Anyway": Patients' Perception of Risk and Willingness to Accept Risks Associated With Thrombolytic Drug Treatment for Acute Stroke 

  Mangset, Margrete; Berge, E.; F rde, R.; Nessa, J.; Wyller, T.B. (2009-01)

  BACKGROUND: Thrombolytic drugs to treat an acute ischaemic stroke reduce the risk of death or major disability. The treatment is, however, also associated with an increased risk of potentially fatal intracranial bleeding. ...
• The Risk of Transfusion-Associated AIDS: Offering Patients an Active Role in Their Care 

  Shepherd, Lois L. (1992-11)